Comparison of NB‐UVB combination therapy regimens for vitiligo: A systematic review and network meta‐analysis

Background Vitiligo was an autoimmune disease and some guidelines for the management of vitiligo encouraged the use of NB‐UVB combination therapies to enhance repigmentation. Objectives To compare the effectiveness of current NB‐UVB combination regimen at the improvement in repigmentation through a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cosmetic dermatology 2023-03, Vol.22 (3), p.1083-1098
Hauptverfasser: Zhu, Baohua, Liu, Chengjiang, Zhang, Lan, Wang, Jun, Chen, Mingling, Wei, Yuegang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Vitiligo was an autoimmune disease and some guidelines for the management of vitiligo encouraged the use of NB‐UVB combination therapies to enhance repigmentation. Objectives To compare the effectiveness of current NB‐UVB combination regimen at the improvement in repigmentation through a systematic review and network meta‐analysis. Methods We searched the electronic databases for randomized controlled trials related to NB‐UVB combination therapy for vitiligo till October 2022. STATA15.0 software was applied to carrying out data analysis. Results A total of 28 eligible studies involving 1194 participants were enrolled in the analysis. The NMA results revealed that compared with NB‐UVB, carboxytherapy [OR = 32.35, 95% CI (1.79, 586.05)], Er: YAG laser+ topical 5% 5‐FU [OR = 10.74, 95% CI (4.05, 28.49)], needling/micro‐needling [OR = 3.42, 95% CI (1.18, 9.88)], betamethasone intramuscular injection [OR = 3.08, 95% CI (1.17, 8.13)], topical tacrolimus [OR = 2.54, 95% CI (1.30, 4.94)], and oral Chinese herbal medicine compound [OR = 2.51, 95% CI (1.40, 4.50)] integrated with NB‐UVB were more efficacious in excellent to complete repigmentation response rate (≥75%). Besides, NB‐UVB+ Er: YAG laser+ topical 5% 5‐FU [OR = 0.17, 95% CI (0.04, 0.67)] and NB‐UVB+ needling/micro‐needling [OR = 0.24, 95% CI (0.06, 0.88)] were less likely evaluated as ineffective repigmentation response (≤25%). Conclusions All combination therapies ranked higher than NB‐UVB monotherapy in inducing successful repigmentation and avoiding failed treatment in patients with vitiligo. Comprehensive consideration, NB‐UVB+ Er: YAG laser+ topical 5% 5‐FU and NB‐UVB+ needling/microneedling would be the preferred therapeutic approaches.
ISSN:1473-2130
1473-2165
DOI:10.1111/jocd.15534